Creating an Innovative AI-based Technology TCRact for Designing and Optimizing T-cell Receptors (TCR) for Use in Cancer Immunotherapies

CompletedOBSERVATIONAL
Enrollment

118

Participants

Timeline

Start Date

October 6, 2021

Primary Completion Date

December 5, 2022

Study Completion Date

December 28, 2023

Conditions
Colon CancerCancer
Interventions
OTHER

Collection of blood (PBMC), biopsy (FFPE) and stool samples.

Patients receiving routine treatment financed by the Polish National Health Fund (NFZ).

Trial Locations (1)

Unknown

Maria Sklodowska-Curie National Research Institute of Oncology, Krakow

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

National Center for Research and Development, Poland

OTHER

lead

Ardigen

INDUSTRY